Go Pro

Tejara Capital Ltd Takes $8.47 Million Position in Certara, Inc. $CERT

Certara logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Tejara Capital acquired 1.29 million Certara shares worth approximately $8.47 million, representing about 0.85% of the company and 3.5% of Tejara’s portfolio.
  • Institutional investors own 73.96% of Certara, while analyst sentiment is broadly neutral: the stock has an average “Hold” rating and an average price target of $8.28.
  • Certara reported quarterly revenue of $93.27 million, below the $98.09 million consensus estimate, while EPS of $0.08 also missed expectations; revenue declined 10.8% year over year.
  • Five stocks we like better than Certara.

Tejara Capital Ltd bought a new position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,292,721 shares of the company's stock, valued at approximately $8,467,000. Certara accounts for 3.5% of Tejara Capital Ltd's investment portfolio, making the stock its 9th biggest position. Tejara Capital Ltd owned about 0.85% of Certara at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Osaic Holdings Inc. grew its position in shares of Certara by 50.7% during the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock valued at $41,000 after purchasing an additional 1,175 shares in the last quarter. Corient Private Wealth LLC boosted its stake in Certara by 11.7% in the second quarter. Corient Private Wealth LLC now owns 12,362 shares of the company's stock worth $144,000 after buying an additional 1,295 shares in the last quarter. Central Pacific Bank Trust Division grew its position in Certara by 8.7% during the second quarter. Central Pacific Bank Trust Division now owns 19,460 shares of the company's stock valued at $127,000 after acquiring an additional 1,558 shares during the last quarter. Treasurer of the State of North Carolina grew its position in Certara by 2.9% during the second quarter. Treasurer of the State of North Carolina now owns 56,628 shares of the company's stock valued at $663,000 after acquiring an additional 1,597 shares during the last quarter. Finally, Nicolet Advisory Services LLC raised its stake in shares of Certara by 7.4% during the third quarter. Nicolet Advisory Services LLC now owns 30,608 shares of the company's stock worth $396,000 after acquiring an additional 2,100 shares in the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CERT. Barclays upped their price objective on shares of Certara from $6.50 to $7.50 and gave the company an "equal weight" rating in a research note on Wednesday, August 5th. BMO Capital Markets lowered their price target on shares of Certara from $7.00 to $6.00 and set a "market perform" rating for the company in a research note on Tuesday, May 12th. Craig Hallum cut their price target on shares of Certara from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Tuesday, May 12th. Robert W. Baird reduced their price objective on Certara from $7.00 to $6.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 12th. Finally, Stephens decreased their price objective on Certara from $10.00 to $9.00 and set an "overweight" rating on the stock in a report on Tuesday, May 12th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $8.28.

Get Our Latest Research Report on CERT

Certara Stock Up 4.4%

CERT stock opened at $8.73 on Friday. The business's 50 day moving average price is $7.05 and its two-hundred day moving average price is $6.44. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.55 and a current ratio of 2.55. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of -19.40 and a beta of 1.44. Certara, Inc. has a fifty-two week low of $4.45 and a fifty-two week high of $13.88.

Certara (NASDAQ:CERT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). Certara had a negative net margin of 16.75% and a positive return on equity of 3.86%. The firm had revenue of $93.27 million for the quarter, compared to analysts' expectations of $98.09 million. During the same period in the prior year, the business posted $0.07 EPS. The business's quarterly revenue was down 10.8% compared to the same quarter last year. As a group, analysts forecast that Certara, Inc. will post 0.22 earnings per share for the current fiscal year.

Certara Profile

(Free Report)

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company's platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company's offerings are divided into software tools and consulting services.

See Also

Want to see what other hedge funds are holding CERT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Certara, Inc. (NASDAQ:CERT - Free Report).

Institutional Ownership by Quarter for Certara (NASDAQ:CERT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Certara Right Now?

Before you consider Certara, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Certara wasn't on the list.

While Certara currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines